Enhanced Surveillance for New Vaccine Preventable Diseases
Enhanced Surveillance for New Vaccine Preventable Diseases
批准号:
9335184
负责人:
NATASHA Bassam HALASA
金额:
$100.0万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-09-01 至 2021-08-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
CORE Component: Acute gastroenteritis (AGE) and acute respiratory illness (ARI) are the leading causes of
death worldwide in children <5 years old beyond the neonatal period. The primary established leading viral
etiologies of AGE are rotavirus and norovirus and respiratory syncytial virus (RSV) and influenza for ARI. Our
understanding of AGE and ARI epidemiology is constantly changing due to seasonal fluctuations, discovery of
new or re-emerging pathogens, and use of rotavirus and influenza vaccines. Hence, surveillance efforts are
imperative to better understand AGE and ARI disease burden, causative pathogens, outcomes, and vaccine
impact. Our team of Vanderbilt investigators is highly experienced in conducting prospective, population-based
AGE and ARI surveillance with laboratory-confirmed enteric and respiratory viruses. For this project, we
propose to conduct prospective AGE and ARI surveillance in Davidson County, TN, with the following specific
aims for the core component: 1) To determine age-specific association rates of AGE with specific enteric
viruses using active, population-based surveillance for laboratory-confirmed gastroenteritis viruses in children
presenting to the emergency department and in hospitalized children. 2) To determine age-specific association
rates of ARI with specific respiratory viruses using active, population-based surveillance for laboratory-
confirmed respiratory viruses in children presenting to the emergency department and in inpatient hospitalized
children. 3) To determine annual influenza vaccine efficacy (VE) in preventing hospitalizations of children <18
years of age due to laboratory-confirmed influenza using a test-negative study design.
OPTIONAL Component: As part of the optional component of the grant, we plan to establish a birth cohort of
250 children; infants will be followed from birth through their second birthday, death, or lost to follow-up,
whichever comes first. We will systemically collect specimens (e.g., respiratory, stool, and blood) to understand
the natural history of AGE and ARI pathogens during early childhood and to understand immunological and
epidemiological factors that can affect symptomatic and asymptomatic status. The specific aims for the
optional component include:1) To establish a prospective birth cohort of children who reside
Nashville/Davidson County, TN to study etiologic, sociodemographic, environmental, and immunologic factors
associated with childhood ARI and AGE and the dynamics of household transmission of respiratory and
gastrointestinal infections during the first two years of life. 2) To determine the natural history of respiratory
infections and host immune responses related to symptomatic and asymptomatic periods in the birth cohort
over two years. 3) To determine the natural history of gastrointestinal infections and host immune responses
related to symptomatic and asymptomatic periods in the birth cohort over two years.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
-
批准号:10576411
-
项目类别:
-
资助金额:$83.85万
-
财政年份:2022
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Comparison of High Dose vs. Standard Dose Influenza Vaccines in Lung Allograft Recipients
-
批准号:10405753
-
项目类别:
-
资助金额:$91.34万
-
财政年份:2022
-
负责人:NATASHA Bassam HALASA
-
依托单位:
IP21-002 Enhanced Surveillance for New Vaccine Preventable Diseases
-
批准号:10669094
-
项目类别:
-
资助金额:$275.0万
-
财政年份:2021
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Enhanced Surveillance for New Vaccine Preventable Diseases
-
批准号:10345655
-
项目类别:
-
资助金额:$144.16万
-
财政年份:2021
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Enhanced Surveillance for New Vaccine Preventable Diseases
-
批准号:10469296
-
项目类别:
-
资助金额:$193.6万
-
财政年份:2021
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
-
批准号:10447747
-
项目类别:
-
资助金额:$82.38万
-
财政年份:2020
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
-
批准号:10246980
-
项目类别:
-
资助金额:$83.84万
-
财政年份:2020
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
-
批准号:10661582
-
项目类别:
-
资助金额:$81.43万
-
财政年份:2020
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Comparison of High vs. Standard Dose Influenza Vaccines in Adult Solid Organ Transplant Recipients
-
批准号:10017602
-
项目类别:
-
资助金额:$86.28万
-
财政年份:2020
-
负责人:NATASHA Bassam HALASA
-
依托单位:
High vs. Standard Dose Flu Vaccine in Adult Stem Cell Transplant Recipients
-
批准号:9352550
-
项目类别:
-
资助金额:$83.27万
-
财政年份:2017
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Comparison of High vs. Standard Dose Flu Vaccine in Pediatric Stem Cell Transplant Recipients
-
批准号:9144608
-
项目类别:
-
资助金额:$171.16万
-
财政年份:2016
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Enhanced Surveillance for New Vaccine Preventable Diseases
-
批准号:9769593
-
项目类别:
-
资助金额:$100.0万
-
财政年份:2016
-
负责人:NATASHA Bassam HALASA
-
依托单位:
Enhanced Surveillance for New Vaccine Preventable Diseases
-
批准号:9990628
-
项目类别:
-
资助金额:$25.0万
-
财政年份:2016
-
负责人:NATASHA Bassam HALASA
-
依托单位:
NEW VACCINE SURVEILLANCE NETWORK
-
批准号:8810751
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2011
-
负责人:NATASHA Bassam HALASA
-
依托单位:
NEW VACCINE SURVEILLANCE NETWORK
-
批准号:8475975
-
项目类别:
-
资助金额:$31.71万
-
财政年份:2011
-
负责人:NATASHA Bassam HALASA
-
依托单位:
NEW VACCINE SURVEILLANCE NETWORK
-
批准号:8308940
-
项目类别:
-
资助金额:$21.01万
-
财政年份:2011
-
负责人:NATASHA Bassam HALASA
-
依托单位:
NEW VACCINE SURVEILLANCE NETWORK
-
批准号:8710055
-
项目类别:
-
资助金额:$24.13万
-
财政年份:2011
-
负责人:NATASHA Bassam HALASA
-
依托单位:
NEW VACCINE SURVEILLANCE NETWORK
-
批准号:8703301
-
项目类别:
-
资助金额:$39.15万
-
财政年份:2011
-
负责人:NATASHA Bassam HALASA
-
依托单位:
NEW VACCINE SURVEILLANCE NETWORK
-
批准号:8495121
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2011
-
负责人:NATASHA Bassam HALASA
-
依托单位:
NEW VACCINE SURVEILLANCE NETWORK
-
批准号:9077576
-
项目类别:
-
资助金额:$38.57万
-
财政年份:2011
-
负责人:NATASHA Bassam HALASA
-
依托单位:
海外基金